Clinical trial
Development of Artificial Intelligence Risk Prediction Model for Upper Digestive Tract Cancer Using High Resolution Endoscopic Image, Digital Pathology, Genetics, and Oro-gastro-intestinal Microbiota.
NCT07605312 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Development of Artificial Intelligence Risk Prediction Model for Upper Digestive Tract Cancer Using High Resolution Endoscopic Image, Digital Pathology, Genetics, and Oro-gastro-intestinal Microbiota.
- Lead sponsor
- National Taiwan University Hospital
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- May 18, 2026
- Completion date
- May 18, 2030
- Enrollment
- 10,000 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
atrophic gastritis, dysplasia stomach, esophageal cancer (esc), gastric cancer (gc), gastric intestinal metaplasia, premalignant lesion